Author Question: A third generation of more successful prevention efforts for eating disorders does not directly ... (Read 40 times)

madam-professor

  • Hero Member
  • *****
  • Posts: 584
A third generation of more successful prevention efforts for eating disorders does not directly focus on body image or disordered eating. These efforts attack the thinness ideal indirectly, or focus on
 
  a. eliminating unhealthy eating habits rather than promoting healthy habits.
  b. promoting healthy eating rather than eliminating unhealthy habits.
  c. encouraging healthy communications styles in families.
  d. eliminating unhealthy communication styles in families.

Question 2

How do long-term outcomes for the treatment of anorexia nervosa compare to long-term outcomes for the treatment of bulimia nervosa?
 
  a. The long-term success is greater for bulimia nervosa.
  b. The long-term success is greater for anorexia nervosa.
  c. There is no difference in long-term outcomes for treating these disorders.
  d. Although there is a higher mortality rate for anorexia, the success of treatment is otherwise better for anorexia.



nicoleclaire22

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

Answer: b.

Answer to Question 2

Answer: a.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library